Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

Zecotek Photonics raises $3.5M

BioPhotonics
Nov 2013
Zecotek Photonics Inc. of Vancouver, British Columbia, Canada, has sold more than 5.9 million shares of company stock at a price of 58 cents a share to raise approximately $3.5 million.

The sale increases the nonbrokered private placement the company announced in August by an additional $260,000 to a total of $3,460,824. Zecotek said it will use the funds to complete the transfer of technology for commercialization, strengthen its IP portfolio, and finance purchase orders and general working capital needs. In June, the company announced that it had raised $2.4 million.

Founded in 2004, Zecotek Photonics develops scintillation crystals, photodetectors, positron emission tomography scanning technologies, 3-D autostereoscopic displays, and lasers for medical, high-tech and industrial applications under three divisions: Imaging Systems, Laser Systems and 3-D Display Systems.

In other Zecotek news, Hamamatsu Photonics of Tokyo has placed a $500,000 order with Zecotek for scintillation crystals to be used in third-party positron emission tomography (PET) scanners. This is the first order since July’s announcement of a joint collaboration agreement between Singapore-based subsidiary Zecotek Imaging Systems Pte Ltd. and optoelectronic components supplier Hamamatsu Photonics KK.

BiophotonicsBusinessRapidScan

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.